Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 14;289(11):7257-63.
doi: 10.1074/jbc.C113.544759. Epub 2014 Feb 4.

A role for mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) in the regulation of hepatic gluconeogenesis

Affiliations

A role for mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) in the regulation of hepatic gluconeogenesis

Romana Stark et al. J Biol Chem. .

Abstract

Synthesis of phosphoenolpyruvate (PEP) from oxaloacetate is an absolute requirement for gluconeogenesis from mitochondrial substrates. Generally, this reaction has solely been attributed to the cytosolic isoform of PEPCK (PEPCK-C), although loss of the mitochondrial isoform (PEPCK-M) has never been assessed. Despite catalyzing the same reaction, to date the only significant role reported in mammals for the mitochondrial isoform is as a glucose sensor necessary for insulin secretion. We hypothesized that this nutrient-sensing mitochondrial GTP-dependent pathway contributes importantly to gluconeogenesis. PEPCK-M was acutely silenced in gluconeogenic tissues of rats using antisense oligonucleotides both in vivo and in isolated hepatocytes. Silencing PEPCK-M lowers plasma glucose, insulin, and triglycerides, reduces white adipose, and depletes hepatic glycogen, but raises lactate. There is a switch of gluconeogenic substrate preference to glycerol that quantitatively accounts for a third of glucose production. In contrast to the severe mitochondrial deficiency characteristic of PEPCK-C knock-out livers, hepatocytes from PEPCK-M-deficient livers maintained normal oxidative function. Consistent with its predicted role, gluconeogenesis rates from hepatocytes lacking PEPCK-M are severely reduced for lactate, alanine, and glutamine, but not for pyruvate and glycerol. Thus, PEPCK-M has a direct role in fasted and fed glucose homeostasis, and this mitochondrial GTP-dependent pathway should be reconsidered for its involvement in both normal and diabetic metabolism.

Keywords: Diabetes; GTPase; Gluconeogenesis; Glyceroneogenesis; Intermediary Metabolism; Metabolic Regulation; Metabolic Tracers; Metabolism; Mitochondrial Metabolism; Phosphoenolpyruvate Carboxykinase.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Oxygen consumption and gluconeogenesis from hepatocytes. A, PEPCK-M mRNA levels from hepatocytes isolated from ConASO (white bars) and PCK2ASO (black bars). B and C, PEPCK-M and PEPCK-C protein expression quantified by Western blotting and normalized to actin. Knockdown levels in hepatocytes are indicative of PEPCK-M levels at the time of the in vivo and in vitro studies. D, oxygen consumption rates in hepatocytes incubated in the presence of either 10 mm lactate or pyruvate alone or uncoupled by 100 μm dinitrophenol (DNP) (n = 5/5) in isolated primary hepatocytes ConASO (white bars) and PCK2ASO (black bars) rats (n = 6/6). E, glucose production rates from hepatocytes treated with the indicated concentration of substrate. The percentage of decrease from ConASO is indicated in parentheses for each substrate (n = 6/6). F and G, PEPCK-M and PEPCK-C mRNA levels from isolated hepatocytes acutely transfected (n = 6/6) with control (white bars) or two different siRNAs (PCK2-A and PCK2-B, black bars). H and I, glucose production from hepatocytes incubated with 9 mm lactate and 1 mm pyruvate (H) or 10 mm glutamine or alanine with siRNA PCK-2A (I). Data are presented as mean ± S.E. t test: *, p < 0.05; ***, p < 0.001.
FIGURE 2.
FIGURE 2.
Fed and fasted glucose homeostasis. Rodents were allowed to eat ad lib overnight, and then food was withdrawn at 6 a.m. (Fed) before rodents underwent a 36-h fast (Fasted). A, PEPCK-M mRNA in indicated tissue ConASO (white bars) and PCK2ASO (black bars) rats determined by quantitative PCR. Results are normalized to the control liver mRNA to demonstrate relative abundance of message, and significance is between CONASO and PCK2ASO. WAT, white adipose tissue; BAT, brown adipose tissue. B and C, initial weights (B) and weight loss during and white adipose mass after the 36-h fast (C). E–H, glucose, insulin, glucagon, and corticosterone were measured. Data are shown as mean ± S.E. for n = 14/12 rats. *, p < 0.05; **, p < 0.01; ***, p < 0.001; NS, not significant.
FIGURE 3.
FIGURE 3.
Basal turnover studies from overnight fasted rats. A and B, CONASO (white bars) and PCK2ASO (black bars) rats were given tracer infusions of labeled (A) lactate and (B) glycerol (n = 7/8) for basal turnover calculations. C, the individual differences between glycerol and lactate Ra are indicative of a substantial switch in gluconeogenic precursor preference. Data are presented as mean ± S.E., **, p < 0.01; ***, p < 0.001.

Similar articles

Cited by

References

    1. Hundal R. S., Krssak M., Dufour S., Laurent D., Lebon V., Chandramouli V., Inzucchi S. E., Schumann W. C., Petersen K. F., Landau B. R., Shulman G. I. (2000) Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49, 2063–2069 - PMC - PubMed
    1. Magnusson I., Rothman D. L., Katz L. D., Shulman R. G., Shulman G. I. (1992) Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J. Clin. Invest. 90, 1323–1327 - PMC - PubMed
    1. Gastaldelli A., Miyazaki Y., Pettiti M., Buzzigoli E., Mahankali S., Ferrannini E., DeFronzo R. A. (2004) Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. J. Clin. Endocrinol. Metab. 89, 3914–3921 - PubMed
    1. Maggs D. G., Buchanan T. A., Burant C. F., Cline G., Gumbiner B., Hsueh W. A., Inzucchi S., Kelley D., Nolan J., Olefsky J. M., Polonsky K. S., Silver D., Valiquett T. R., Shulman G. I. (1998) Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 128, 176–185 - PubMed
    1. Owen O. E., Kalhan S. C., Hanson R. W. (2002) The key role of anaplerosis and cataplerosis for citric acid cycle function. J. Biol. Chem. 277, 30409–30412 - PubMed

Publication types

MeSH terms

LinkOut - more resources